| Financial Year |
March 31 2023 |
| Monetary Funds |
536,538,720.19 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,805,972.41 |
| Accounts Receivable |
505,958,612.21 |
| Advances to Suppliers |
26,911,232.93 |
| Other Receivables |
34,175,013.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
907,880,454.92 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
43,319,308.12 |
| Total Current Assets |
2,072,293,057.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
2,146,538.39 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
1,360,488,368.61 |
| Under-construction Projects |
23,470,748.57 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,998,147,635.05 |
| R&D expenses |
-- |
| Goodwill |
1,019,054,082.38 |
| Long-Term Deferred and Prepaid Expenses |
46,459,003.38 |
| Deferred Income Tax Assets |
158,535,555.63 |
| Other Non-Current Assets |
37,681,007.86 |
| Sub-Total of Non-Current Assets |
4,915,159,003.53 |
| Total Assets |
6,987,452,060.85 |
| Short-Term Loans |
246,358,911.55 |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,000,000.00 |
| Accounts Payable |
218,363,038.35 |
| Accounts Received In Advance |
41,097,528.35 |
| Employee Compensation Payable |
216,374,488.88 |
| Taxes Payable |
53,759,787.56 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
153,124,286.07 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
252,741,668.51 |
| Other Current Liabilities |
9,126,219.74 |
| Sub-Total of Current Liabilities |
1,291,056,744.33 |
| Long-term Loans |
1,955,381,183.63 |
| Bonds Payable |
785,690,669.84 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
531,959,251.81 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,532,075,854.73 |
| Total Liabilities |
4,823,132,599.06 |
| Paid-In Capital(Or Share Stock) |
587,410,546.00 |
| Capital Surplus |
812,726,028.23 |
| Surplus Reserve |
104,295,133.50 |
| LESS:Treasury Stock |
40,687,000.00 |
| Undistributed Profits |
869,621,767.07 |
| Minority Stockholder's Interest |
145,855,169.17 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,018,464,292.62 |
| Owner's Equity（Stockholder's Equity） |
2,164,319,461.79 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,987,452,060.85 |
